CAT-1004 (Catabasis) Clinical Trial Webinar [May 2015] On May 13, 2015, Dr. Joanne Donovan, Chief Medical Officer at Catabasis Pharmaceuticals, presented information about MoveDMD: an upcoming Phase 1/2 clinical trial with CAT-1004 in boys with Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 10 years ago You may also like 1:01:09 Connect with the Experts: Endocrine Series – Height and Weight 4 years ago Care Webinars,Webinars 50:05 Catabasis Phase 3 PolarisDMD Trial Results (October 27, 2020) 4 years ago Research & Clinical Trial Webinars,Webinars 49:45 Connect with the Experts: Endocrine Series – Delayed Puberty 4 years ago Care Webinars,Webinars 1:04:36 Connect with the Experts: Endocrine Series – Bone Health 4 years ago Care Webinars,PPMD Adult Advisory Committee (PAAC) Webinars,Webinars 1:31:01 Resiliency in Results – What We Learn When Trials Are Terminated (September 16, 2020) 4 years ago Research & Clinical Trial Webinars,Webinars 58:11 NS Pharma Announcement of VILTEPSO™ (August 26, 2020) 4 years ago Research & Clinical Trial Webinars,Webinars 52:47 Family Friday: Thriving in the Virtual Classroom 4 years ago Family Friday,Webinars 1:00:32 2020 Back-To-School Series: Thriving in the Virtual Classroom (August 19, 2020) 4 years ago Care Webinars,COVID-19 Webinars,Webinars «1…89101112…25»Page 10 of 25
by: Parent Project Muscular Dystrophy
